Bicycle Therapeutics (BCYC) Other Non-Current Assets (2018 - 2026)
Bicycle Therapeutics (BCYC) reported Other Non-Current Assets of $13.0 million for Q1 2026, up 5.11% on a YoY basis from $12.4 million in Q1 2025, and up 1.46% quarter-over-quarter from $12.8 million in Q4 2025.
Bicycle Therapeutics (BCYC) Other Non-Current Assets (2018 - 2026) Analysis & Trends
Bicycle Therapeutics has reported Other Non-Current Assets for 9 years, with the latest figure at $13.0 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets rose 5.11% year-over-year to $13.0 million; the trailing twelve-month figure through Mar 2026 stood at $13.0 million (up 5.11% YoY), and the FY2025 full-year result was $12.8 million, up 15.63% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $13.0 million, up from $12.8 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $13.8 million in Q2 2025, with the low at $4.2 million in Q1 2022.
- Historically, Other Non-Current Assets has averaged $9.3 million across 5 years, with a median of $9.9 million in 2024.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets jumped 151.69% — and 2024, when it sank 45.83%.
- Bicycle Therapeutics' Other Non-Current Assets stood at $8.5 million in 2022, then tumbled by 31.52% to $5.8 million in 2023, then jumped by 91.19% to $11.1 million in 2024, then increased by 15.63% to $12.8 million in 2025, then increased by 1.46% to $13.0 million in 2026.
- The last three Other Non-Current Assets figures came in at $13.0 million (Q1 2026), $12.8 million (Q4 2025), and $13.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Bicycle Therapeutics | 278.04 Mn | 278.04 Mn | - | 12.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.99 Mn |
| Dec 31, 2025 | 12.81 Mn |
| Sep 30, 2025 | 13.71 Mn |
| Jun 30, 2025 | 13.81 Mn |
| Mar 31, 2025 | 12.36 Mn |
| Dec 31, 2024 | 11.07 Mn |
| Sep 30, 2024 | 9.94 Mn |
| Jun 30, 2024 | 6.58 Mn |
| Mar 31, 2024 | 6.37 Mn |
| Dec 31, 2023 | 5.79 Mn |
| Sep 30, 2023 | 5.45 Mn |
| Jun 30, 2023 | 12.15 Mn |
| Mar 31, 2023 | 10.57 Mn |
| Dec 31, 2022 | 8.46 Mn |
| Sep 30, 2022 | 6.16 Mn |
| Jun 30, 2022 | 5.10 Mn |
| Mar 31, 2022 | 4.20 Mn |
| Dec 31, 2021 | 3.45 Mn |
| Sep 30, 2021 | 2.78 Mn |
| Jun 30, 2021 | 2.38 Mn |